Literature DB >> 2536908

The multicentric nature of disease related to human papillomavirus infection of the female lower genital tract.

M Spitzer1, B A Krumholz, V L Seltzer.   

Abstract

Two hundred fifty-one consecutive patients from our colposcopy clinic were evaluated to establish the extent to which human papillomavirus (HPV) infection is a disease of the entire female lower genital tract. Colposcopic examinations and biopsies of the cervix and vulva were performed on all patients. Two hundred two women had cervical disease, of whom 164 (81%) also had vulvar disease. The percentage was the same regardless of the severity of the cervical disease. One hundred ninety-four of the patients had vulvar disease and of these, 164 (85%) also had cervical disease. Twenty-nine of 37 women (78%) with overt vulvar condylomata had cervical disease; 15 of these presented without a Papanicolaou smear, and 13 had cervical disease. We conclude that HPV infection of the female lower genital tract is a multicentric disease. All patients with evidence of HPV infection should undergo colposcopic evaluation of the entire lower genital tract. The significance that this will have on future attempts to cure this infection needs to be studied.

Entities:  

Mesh:

Year:  1989        PMID: 2536908

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile.

Authors:  Monika Hampl; Nicolas Wentzensen; Svetlana Vinokurova; Magnus von Knebel-Doeberitz; Cristopher Poremba; Hans G Bender; Volkmar Kueppers
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-25       Impact factor: 4.553

2.  Yield of Cytology Surveillance After High-Grade Vulvar Intraepithelial Neoplasia or Cancer.

Authors:  Lindsay M Kuroki; Antonina I Frolova; Ningying Wu; Jingxia Liu; Matthew Powell; Premal H Thaker; L Stewart Massad
Journal:  J Low Genit Tract Dis       Date:  2017-07       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.